famotidine has been researched along with Erosive Duodenitis in 5 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filimonov, RM | 1 |
| Musaeva, OM | 1 |
| Moriyama, T | 1 |
| Matsumoto, T | 1 |
| Jo, Y | 1 |
| Yada, S | 1 |
| Hirahashi, M | 1 |
| Yao, T | 1 |
| Iida, M | 1 |
| Okhlobystin, AV | 1 |
| Blanco, M | 1 |
| Pajares, JM | 1 |
| Jimenez, ML | 1 |
| Lopez-Brea, M | 1 |
| Haga, K | 1 |
| Asano, K | 1 |
| Osuga, K | 1 |
| Maruyama, Y | 1 |
2 trials available for famotidine and Erosive Duodenitis
| Article | Year |
|---|---|
[Laser therapy and famotidine in complex restorative treatment of primary chronic gastroduodenitis].
Topics: Chronic Disease; Combined Modality Therapy; Duodenitis; Famotidine; Female; Histamine H2 Antagonists | 2003 |
Effect of acid inhibition on Campylobacter pylori.
Topics: Adult; Campylobacter; Campylobacter Infections; Duodenitis; Famotidine; Female; Gastric Acid; Gastri | 1988 |
3 other studies available for famotidine and Erosive Duodenitis
| Article | Year |
|---|---|
Mucosal proinflammatory cytokine and chemokine expression of gastroduodenal lesions in Crohn's disease.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Case-Control Studies; Chemokines; Crohn Disease; Cytokin | 2005 |
[Properties of a new drug famocid: indications and contraindications of its use?].
Topics: Contraindications; Duodenitis; Famotidine; Gastritis; Humans; Kidney; Liver; Peptic Ulcer | 1995 |
[Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
Topics: Animals; Dogs; Duodenitis; Famotidine; Female; Gastric Acid; Histamine H2 Antagonists; Male; Omepraz | 1988 |